UBS raised the firm’s price target on Chime (CHYM) to $27 from $24 and keeps a Neutral rating on the shares. The firm updated its model following the Q4 earnings report.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CHYM: